3 ways to accelerate development and de-risk cell and gene therapy manufacturing

3 ways to accelerate development and de-risk cell and gene therapy manufacturing

Development strategies designed to reduce the unknowns so that cell and gene therapy innovators can develop robust processes efficiently.

Helping Employers Prepare for Gene and Cellular Therapies

Gene and cellular therapies are exceedingly rare – sometimes one-in-a-million rare. They’re generally a person’s last option after doctors have exhausted all other treatment approaches to a life-threatening disease or condition. And because of their singular, curative qualities, they’re enormously expensive, with price tags that can surpass $4 million. “That sounds like a lot – and it is,” said Gary Petruzzelli, Vice President of Pharmacy at Cap…